Literature DB >> 33142624

Characterization and anti-diabetic nephropathic ability of mycelium polysaccharides from Coprinus comatus.

Zheng Gao1, Deyin Kong1, Wenxin Cai1, Jianjun Zhang2, Le Jia3.   

Abstract

It seems quite necessary for obtaining effective substances from natural products against the diabetic nephropathic (DN) with the presently clinical problems of accompanying side-effects and lowing life qualities. This work aimed to characterize the primary structure of Coprinus comatus mycelium polysaccharides (CMP) and investigate the abilities against DN in streptozotocin induced mice models. The results indicated that CMP could improve insulin resistance and energy metabolism, and significantly suppress dysfunction on kidney and relieve the renal oxidative stress and inflammation in DN mice. Besides, the western blot results suggested that CMP reversed renal injury by modulating the PTEN/PI3K/Akt and Wnt-1/β-catenin pathways. The structure analysis indicated the typical characterizations with the major monosaccharide-compositions of galactose, α-pyranose configuration and proper molecular weights of 495.8 kDa possibly contributed to the anti-diabetic nephropathic effects of CMP. The results suggested that polysaccharides form C. comatus could be used as functional foods/drugs on preventing diabetic nephropathy.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antioxidation; Coprinus comatus; Diabetic nephropathy; PTEN/PI3K/Akt pathway; Wnt-1/β-catenin pathway

Mesh:

Substances:

Year:  2020        PMID: 33142624     DOI: 10.1016/j.carbpol.2020.117081

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  5 in total

1.  Ginsenoside Rg1 attenuates the inflammation and oxidative stress induced by diabetic nephropathy through regulating the PI3K/AKT/FOXO3 pathway.

Authors:  Hui Liu; Wenli Chen; Ping Lu; Yifei Ma; Xinjun Liang; Yanyan Liu
Journal:  Ann Transl Med       Date:  2021-12

2.  Effect of Lycium barbarum Polysaccharide on Decreasing Serum Amyloid A3 Expression through Inhibiting NF-κB Activation in a Mouse Model of Diabetic Nephropathy.

Authors:  Fengqi Wan; Fulin Ma; Jiaxin Wu; Xinyu Qiao; Minxue Chen; Wenjian Li; Liang Ma
Journal:  Anal Cell Pathol (Amst)       Date:  2022-01-29       Impact factor: 2.916

Review 3.  Medicinal Components in Edible Mushrooms on Diabetes Mellitus Treatment.

Authors:  Arpita Das; Chiao-Ming Chen; Shu-Chi Mu; Shu-Hui Yang; Yu-Ming Ju; Sing-Chung Li
Journal:  Pharmaceutics       Date:  2022-02-17       Impact factor: 6.321

4.  Slowly Digestible Carbohydrate Diet Ameliorates Hyperglycemia and Hyperlipidemia in High-Fat Diet/Streptozocin-Induced Diabetic Mice.

Authors:  Yu-Zhong Chen; Jia Gu; Wei-Ting Chuang; Ya-Fang Du; Lin Zhang; Meng-Lan Lu; Jia-Ying Xu; Hao-Qiu Li; Yan Liu; Hao-Tian Feng; Yun-Hong Li; Li-Qiang Qin
Journal:  Front Nutr       Date:  2022-04-15

5.  Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway.

Authors:  Yan-Ni Wang; Hong-Jiao Liu; Li-Li Ren; Ping Suo; Liang Zou; Ya-Mei Zhang; Xiao-Yong Yu; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.